- Home
- CDXS vs STRS Comparison
CDXS vs STRS Comparison
Compare CDXS & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDXS | STRS |
|---|---|---|
| Founded | 2002 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Homebuilding |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 220.4M |
| IPO Year | 2008 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CDXS | STRS |
|---|---|---|
| Price | $1.49 | $19.85 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 796.1K | 92.5K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.82 | ★ 512.50 |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $138,590,000.00 | $29,914,000.00 |
| Revenue This Year | $7.73 | N/A |
| Revenue Next Year | $14.24 | N/A |
| P/E Ratio | ★ N/A | $24.22 |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $15.35 |
| 52 Week High | $3.87 | $32.93 |
Technical Indicators
Market Signals| Indicator | CDXS | STRS |
|---|---|---|
| Relative Strength Index (RSI) | 23.79 | 15.54 |
| Support Level | $1.10 | $18.51 |
| Resistance Level | $1.86 | $20.57 |
| Average True Range (ATR) | 0.15 | 1.05 |
| MACD | -0.07 | -0.38 |
| Stochastic Oscillator | 5.33 | 3.96 |
Price Performance
Historical ComparisonAbout CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the entitlement, development, management, leasing, and sale of multi-family and single-family residential and commercial real estate properties in the Austin, Texas area and other select markets in Texas. The company operates in two reportable segments: Real Estate Operations and Leasing Operations. Maximum revenue is generated from the Leasing Operations segment, which involves the leasing of commercial and residential properties developed by the company. The Real Estate Operations segment comprises properties under various stages of development: developed for sale, under development, and available for development.